eMedicine Specialties > Infectious Diseases > CNS Infections

Eastern Equine Encephalitis: Differential Diagnoses & Workup

Author: Mohan Nandalur, MD, Staff Physician, Department of Internal Medicine, Section of Cardiovascular Medicine, Washington Hospital Center
Coauthor(s): Andrew W Urban, MD, Chief, Section of Infectious Diseases, Middleton Memorial Veterans Hospital; Clinical Assistant Professor, Department of Internal Medicine, University of Wisconsin at Madison
Contributor Information and Disclosures

Updated: Oct 31, 2007

Differential Diagnoses

Bartonellosis
Leptospirosis
Brucellosis
Listeria Monocytogenes
California Encephalitis
Lyme Disease
Coxsackieviruses
Malaria
Cryptococcosis
Naegleria Infection
Cysticercosis
Rabies
Cytomegalovirus
Tuberculosis
Echinococcosis Hydatid Cyst
Western Equine Encephalitis
Histoplasmosis
Japanese Encephalitis
Legionnaires Disease

Other Problems to Be Considered

Mumps
Stroke
Metabolic encephalopathy
Reye syndrome
Bartonella infection
Cytomegalovirus
Ebstein-Barr virus
Prion disease
Toxic ingestions
AIDS

Workup

Laboratory Studies

  • Because of the numerous organisms that can produce signs and symptoms similar to those of eastern equine encephalitis (EEE), clinical diagnosis is difficult. Likewise, laboratory confirmation is challenging because it requires either specific serologic findings or virus isolation in brain tissue or CSF. If the possibility of EEE is considered early, recovery of the virus from the serum during the prodromal phase is possible; however, isolation from either the blood or CSF is often difficult.
  • Blood cultures reveal nothing in this particular disease but may be performed if suspicion of bacterial infection is high.
  • The current CDC diagnosis guidelines of an arbovirus require the presence of an acute febrile illness with encephalitis during a time when viral transmission is likely and one of the following criteria are evident:
    • Greater than 4-fold increase in the viral antibody titer between acute and convalescent sera (often 10 wk apart)
    • Viral isolation from the CSF, blood, or tissue
    • Immunoglobulin M (IgM) positive to the organism in the CSF: Presumptive positives can be made from the remaining biochemical assays (eg, hemoagglutinin inhibition, immunofluorescence, neutralization, complement fixation).
  • Biochemical assays are valuable for EEE diagnosis. With early suspicion, obtain sera at 2- to 3-day intervals. A potential drawback is the slow turnaround time for these test results. Additionally, VecTest antigen assays and Vero cell plaque assays have been in use for arthropod surveillance programs and have also been effective in human diagnosis.1 Potential assays for isolation include the following:
    • Enzyme-linked immunosorbent assay (ELISA) is used to detect IgM, primarily during convalescent stages or prolonged courses.
    • ELISA may be used to detect antiarboviral immunoglobulin G (IgG), which has similar results to the neutralization assay (current use primarily as an adjunct to the IgM ELISA).2
    • Serum hemoagglutinin-inhibition titer of at least 1:320 is most common.
    • Complement fixation titer of at least 1:128 primarily occurs in convalescing patients.
    • Immunofluorescence titer of at least 1:256 is uncommon.
    • Neutralization assay titer of at least 1:160 is common.
  • Few laboratory test abnormalities are particular to EEE. The following are abnormal findings:
    • Leukocytosis has a 95% prevalence rate, with a median of 15,000 cells/µL. It is predominantly neutrophilic, but bands or lymphocytosis may not necessarily be visualized.
    • Hyponatremia often develops, but the exact relationship between the virus being directly responsible and a secondary syndrome of inappropriate secretion of antidiuretic hormone (SIADH) has not been outlined.
  • CSF findings
    • Increases in protein and protein concentration in the CSF, approximately 100 mg/dL, are common.
    • The CSF RBC count may be elevated.
    • The CSF WBC count may be elevated (initial WBC count 500-2000/µL with a median of 600 WBC/µL with a predominance of neutrophils).
    • Hypoglycorrhachia is not present.
  • EEE-specific TaqMan reverse transcriptase polymerase chain reaction (PCR) analysis
    • Use this as a final alternative to analyze the various organisms known to cause encephalitis.
    • This analysis will hopefully provide rapid diagnosis in the future.
    • Recent studies are more promising for PCR because they indicate higher accuracy rates than the 10% likelihood of serological diagnostics for yielding positive virus results.
    • Other current advantages include the ability to target antiviral therapy, the ability to reduce the need for brain biopsies, and the ability to increase the speed of diagnosis (obtaining the panel can occur in 72 hours).
    • The current limitation is that this study likely requires a state or national effort, which may not be available for EEE.

Imaging Studies

Neuroimaging studies (eg, CT scanning, MRI) may aid in early virus identification and are routinely performed in patients with CNS symptoms. Relatively recent advances in imaging show that previous neuroradiographic manifestations of EEE were not precisely defined. Early studies (not entirely sensitive) revealed a predilection for the thalamic nuclei and the basal ganglia3 ; however, these changes are also common in infections with Japanese encephalitis, measles, mumps, echovirus 25, conjunctivitis (CJ) disease, cyanide poisoning, and carbon monoxide (CO) poisoning. Both CT scanning and MRI may play an important role in the early identification of EEE. Of note, most radiographic changes resolve in those patients who recover.

  • CT scanning
    • Perform this test to monitor the evolution of lesions or to determine primary areas of disease.
    • The most common finding is a lesion of the basal ganglia.
    • Lesions vary in size and may exhibit a secondary mass effect with edema.
    • A CT scan may reveal areas of punctate hemorrhage, focal edema with a mass effect, poorly marginated lesions, or interventricular hemorrhage.
    • In elderly patients, the findings can mimic early infarction or they may be nonspecific, which is common in elderly patients.
    • Occasionally, meningeal enhancement may also be present, indicating a subarachnoid hemorrhage or meningitis.
  • MRI
    • MRI often is sensitive to early changes secondary to EEE and aids in a more prompt diagnosis in up to 60% of patients. Compared with CT scanning, MRI is more sensitive and reveals more abnormalities with increased detail.
    • Use a T2-weighted image to best observe the lesions, which appear as areas of increased signal intensity.
    • The most commonly affected areas of the CNS include the basal ganglia (unilateral or asymmetric with occasional internal capsule involvement) and thalamic nuclei. Other areas include the brain stem (often the midbrain), periventricular white matter, and cortex (most often temporally).
    • The MRI findings are abnormal in all comatose patients, and normal MRI findings may indicate the need to consider another diagnosis.
    • MRI also provides critical information in differentiating EEE from herpes encephalitis because EEE is common in the basal ganglia and herpes is not. If attenuation is present in the basal ganglia, herpes tends to occur laterally, whereas EEE has a medial preponderance.

Other Tests

  • EEG: This test often reveals a generalized slowing and disorganization of the background. Later, this condition is followed by epileptiform activity that varies from isolated discharges to gross seizure activity.
  • Culture growth: Previously, the recovery of EEE was limited because only a few facilities had the resources to amplify the virus. Recent studies indicate excellent growth of the virus recovered from patient CSF in A549 and MRC-5 cell cultures, which are mediums that virology laboratories routinely use to recover adenovirus, herpes simplex virus (HSV), and enterovirus.4
  • Brain biopsy: This is rarely indicated and is simply a last resort for diagnosis.

Procedures

  • Obtain a lumbar puncture (LP) as soon as possible when EEE is strongly suspected. Assess the CSF for elevated opening pressures and obtain a CBC count with differential, Gram stain, glucose, protein, bacterial culture, viral culture, fungal culture, acid-fast bacillus, India ink stain, and Venereal Disease Research Laboratory (VDRL) test.

Histologic Findings

CNS histopathology

The perikaryon and dendrites are primarily affected and demonstrate evidence of cytoplasmic swelling, eosinophilia, and nuclear pyknosis. Occasionally, mature viral particles are observed in extracellular spaces. The brain is grossly edematous, and inflammation is evident both parenchymally and perivascularly, as outlined above. Perivascular inflammation, vasculitis, thrombi, neurolysis, neuronophagia, and demyelination may be observed. The predominance of neutrophils in the inflammatory cell type is particularly important.

More on Eastern Equine Encephalitis

Overview: Eastern Equine Encephalitis
Differential Diagnoses & Workup: Eastern Equine Encephalitis
Treatment & Medication: Eastern Equine Encephalitis
Follow-up: Eastern Equine Encephalitis
References

References

  1. Nasci RS, Gottfried KL, Burkhalter KL, et al. Sensitivity of the VecTest antigen assay for eastern equine encephalitis and western equine encephalitis viruses. J Am Mosq Control Assoc. Dec 2003;19(4):440-4. [Medline].

  2. Johnson AJ, Martin DA, Karabatsos N. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol. May 2000;38(5):1827-31. [Medline].

  3. Deresiewicz RL, Thaler SJ, Hsu L. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med. Jun 26 1997;336(26):1867-74. [Medline].

  4. Sotomayor EA, Josephson SL. Isolation of eastern equine encephalitis virus in A549 and MRC-5 cell cultures. Clin Infect Dis. Jul 1999;29(1):193-5. [Medline].

  5. Chang TW, Weinstein L. Antiviral activity of isoprinosine in vitro and in vivo. Am J Med Sci. Feb 1973;265(2):143-6. [Medline].

  6. Elgart ML. Medical pearl: permethrin can prevent arthropod bites and stings. J Am Acad Dermatol. Aug 2004;51(2):289. [Medline].

  7. Anthony RP, Brown DT. Protein-protein interactions in an alphavirus membrane. J Virol. Mar 1991;65(3):1187-94. [Medline].

  8. Brault AC, Powers AM, Chavez CL. Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South america. American Journal of Tropical Medicine and Hygiene. 1999-October;61(4):579-86. [Medline].

  9. Caley IJ, Betts MR, Irlbeck DM. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol. Apr 1997;71(4):3031-8. [Medline].

  10. Dent JH. Pathological changes in the brains of children infected with the virus of eastern equine encephalomyelitis. Bull Tulane Univ Med Fac. Feb 1955;14(2):85-96. [Medline].

  11. Dropulic B, Masters CL. Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endothelium. J Infect Dis. Apr 1990;161(4):685-91. [Medline].

  12. Freier JE. Eastern equine encephalomyelitis. Lancet. Nov 20 1993;342(8882):1281-2. [Medline].

  13. Garen PD, Tsai TF, Powers JM. Human eastern equine encephalitis: immunohistochemistry and ultrastructure. Mod Pathol. Jun 1999;12(6):646-52. [Medline].

  14. Grosfeld H, Lustig S, Gozes Y. Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity. J Virol. Feb 1992;66(2):1084-90. [Medline].

  15. Gutierrez KM, Prober CG. Encephalitis. Identifying the specific cause is key to effective management. Postgrad Med. Mar 1998;103(3):123-5, 129-30, 140-3. [Medline].

  16. Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system [letter]. N Engl J Med. Feb 11 1999;340(6):483-4. [Medline].

  17. Johnson RT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis. Mar 1987;155(3):359-64. [Medline].

  18. Letson GW, Bailey RE, Pearson J. Eastern equine encephalitis (EEE): a description of the 1989 outbreak, recent epidemiologic trends, and the association of rainfall with EEE occurrence. Am J Trop Med Hyg. Dec 1993;49(6):677-85. [Medline].

  19. Long MC, Nagata LP, Ludwig GV. Construction and characterization of monoclonal antibodies against western equine encephalitis virus. Hybridoma. Apr 2000;19(2):121-7. [Medline].

  20. Mandell GL. Principles and Practice of Infectious Disease. 5th ed. New York, NY: Churchill Livingstone; 2000.

  21. Moncayo AC, Edman JD. Toward the incrimination of epidemic vectors of eastern equine encephalomyelitis virus in Massachusetts: abundance of mosquito populations at epidemic foci. J Am Mosq Control Assoc. Dec 1999;15(4):479-92. [Medline].

  22. Obrecht RE, Patrick PD. Neuropsychological sequelae of adolescent infectious diseases. Adolesc Med. Oct 2002;13(3):663-81. [Medline].

  23. Peters CJ, Dalrymple JM. Alphaviruses. Virology. 1990;713-61.

  24. Piliero PJ, Brody J, Zamani A. Eastern equine encephalitis presenting as focal neuroradiographic abnormalities: case report and review. Clin Infect Dis. Jun 1994;18(6):985-8. [Medline].

  25. Roos KL. Encephalitis. Neurol Clin. Nov 1999;17(4):813-33. [Medline].

Further Reading

Keywords

eastern equine encephalitis, EEE, western equine encephalitis, WEE, St Louis encephalitis, La Crosse encephalitis, West Nile encephalitis, meningoencephalitis, viral encephalitis, herpes simplex virus, arboviruses, alphavirus, Togaviridae family, Culiseta melanura, Coquillettidia perturbans, Aedes canadensis, Venezuelan equine encephalitis, North American eastern equine encephalitis, South American eastern equine encephalitis

Contributor Information and Disclosures

Author

Mohan Nandalur, MD, Staff Physician, Department of Internal Medicine, Section of Cardiovascular Medicine, Washington Hospital Center
Mohan Nandalur, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians-American Society of Internal Medicine, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Coauthor(s)

Andrew W Urban, MD, Chief, Section of Infectious Diseases, Middleton Memorial Veterans Hospital; Clinical Assistant Professor, Department of Internal Medicine, University of Wisconsin at Madison
Andrew W Urban, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine
Disclosure: Nothing to disclose.

Medical Editor

Gary L Gorby, MD, Program Director of Adult Infectious Diseases Fellowship, Associate Professor, Department of Internal Medicine, Division of Infectious Disease, St Joseph Medical Center, Creighton University School of Medicine
Gary L Gorby, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and New York Academy of Sciences
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

John L Brusch, MD, FACP, Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance
John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.